75.36 F
New York
September 22, 2021

PFIZER

FDA authorizes Pfizer COVID-19 booster shots for seniors and others at high risk

CBS News
by CBS News00
CBS News – For more and to sign up click here The Food and Drug Administration granted emergency use authorization Wednesday for a third dose of Pfizer and BioNTech’s COVID-19 vaccine to be given to three groups — those 65 and older, those at high risk of developing severe COVID-19......
Read more

FDA considers approving Pfizer vaccine booster shots

CBS News
by CBS News00
CBS News – For more and to sign up click here FDA considers approving Pfizer vaccine booster shots – CBS News Watch CBSN Live The FDA is considering authorizing Pfizer’s COVID vaccine booster shot for those who are high-risk or 65 and older. It comes as the Delta variant surge......
Read more

Johnson & Johnson says COVID booster increases protection

CBS News
by CBS News00
CBS News – For more and to sign up click here Johnson & Johnson says COVID booster increases protection – CBS News Watch CBSN Live Johnson & Johnson said a second dose of its one-shot COVID vaccine offers stronger protection against the disease. Mark Strassmann has the latest. Be the......
Read more

Pfizer says its COVID-19 vaccine is safe and effective in kids ages 5 to 11

CBS News
by CBS News00
CBS News – For more and to sign up click here Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for youngsters. The vaccine made by Pfizer......
Read more

Stocks making the biggest moves premarket: Pfizer, Occidental Petroleum, Bank of America and more

CNBC
by CNBC019
CNBC – For more and to sign up click here A syringe is filled with a dose of Pfizer’s coronavirus disease (COVID-19) vaccine at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., February 23, 2021. Brendan McDermid | Reuters Check out......
Read more

Pfizer says its Covid vaccine is safe and generates robust immune response in kids ages 5 to 11

CNBC
by CNBC099
CNBC – For more and to sign up click here Pfizer and BioNTech‘s Covid-19 vaccine is safe and generates a “robust” immune response in a clinical trial of kids ages 5 to 11, the drugmakers announced in a press release Monday. The companies tested a two-dose regimen of 10 micrograms......
Read more

Debate over COVID-19 booster shots continue as U.S. reports decline in new infections

CBS News
by CBS News00
CBS News – For more and to sign up click here Debate over COVID-19 booster shots continue as U.S. reports decline in new infections – CBS News Watch CBSN Live The debate over the necessity of COVID-19 booster shots is becoming yet another point of contention in public health discourse.......
Read more

FDA panel approves Pfizer boosters for older and high-risk people

CBS News
by CBS News00
CBS News – For more and to sign up click here FDA panel approves Pfizer boosters for older and high-risk people – CBS News Watch CBSN Live President Biden’s plan to give booster shots to most Americans was rejected by an FDA advisory panel just days before its rollout. The......
Read more

The Biden administration is negotiating to buy another 500 million Pfizer doses to donate overseas.

New York Times
by New York Times03
The Biden administration is negotiating with Pfizer to buy another 500 million doses of Covid-19 vaccine to donate overseas, which would bring the total number of planned donations to 1.15 billion doses — about a tenth of the world’s need — according to two people familiar with the plan. It......
Read more

Moderna Vaccine More Effective Than Pfizer, J&J, Especially After 4 Months: CDC

CNBC
by CNBC02
CNBC – For more and to sign up click here Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. Dado Ruvic | Reuters Moderna’s COVID-19 vaccine is slightly more effective than Pfizer’s or Johnson & Johnson’s in preventing hospitalization,......
Read more

FDA advisers to vote on Pfizer’s COVID-19 booster shots

CBS News
by CBS News00
CBS News – For more and to sign up click here A panel of the Food and Drug Administration’s vaccine advisers is meeting Friday to discuss third doses of Pfizer-BioNTech’s COVID-19 vaccine, a key first step towards the Biden administration’s plans to initiate the U.S.’ first booster shots later this......
Read more

The F.D.A.’s vaccine advisory committee is set to consider Pfizer booster shots on Friday.

New York Times
by New York Times025
The Food and Drug Administration’s independent panel of vaccine advisers is set to meet Friday to discuss the case for booster shots of the Pfizer-BioNTech coronavirus vaccine, and to vote on whether the agency should approve additional doses for people 16 and older. The meeting and vote, which could significantly......
Read more

Scientists split on COVID vaccine booster shots

CBS News
by CBS News00
CBS News – For more and to sign up click here Scientists split on COVID vaccine booster shots – CBS News Watch CBSN Live Scientists are debating whether COVID-19 booster shots are necessary for those who are not immunocompromised, with some saying the vaccine is effective enough on its own.......
Read more

Pfizer says Israel data shows third Covid shot restores protection from infection to 95% as it makes case to FDA for boosters

CNBC
by CNBC0132
CNBC – For more and to sign up click here A man receives his third dose of COVID19 vaccine at Sheba Medical Center on July 14, 2021 in Ramat Gan, Israel. Amir Levy | Getty Images A third dose of Pfizer‘s Covid vaccine six months after a second shot restores......
Read more

Pfizer CEO says Covid vaccine data for kids under age 5 may come in late October

CNBC
by CNBC05
CNBC – For more and to sign up click here Pfizer CEO Albert Bourla addresses a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys | Pool | Reuters......
Read more

Pfizer and BioNTech will soon seek clearance for vaccine use in children 5 years and over.

New York Times
by New York Times00
New York Times – For more and to sign up click here The makers of the Pfizer-BioNTech vaccine will soon ask regulators to clearance its use in children 5 years and over, and are getting ready to make smaller doses of the vaccine for younger children, according to one of......
Read more

Pfizer Covid booster shots will likely be ready Sept. 20, but Moderna may be delayed, Fauci says

CNBC
by CNBC0140
CNBC – For more and to sign up click here Top infectious disease expert Dr. Anthony Fauci responds to accusations by Sen. Rand Paul (R-KY) as he testifies before the Senate Health, Education, Labor, and Pensions Committee on Capitol hill in Washington, D.C., U.S., July 20, 2021. J. Scott Applewhite......
Read more

Pfizer on track for U.S. vaccine boosters, Moderna lagging, Fauci says

Reuters
by Reuters00
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during a Senate Health, Education, Labor, and Pensions Committee hearing at the Dirksen Senate Office Building in Washington, D.C., U.S., July 20, 2021. Stefani Reynolds/Pool via REUTERS WASHINGTON, Sept 5 (Reuters) – Top U.S. infectious disease......
Read more

Biden administration’s September 20 booster rollout may be scaled back to just Pfizer Covid-19 vaccine at first

CNN
by CNN00
USA TODAY – For more and to sign up click here There have been internal conversations within the Biden administration about scaling back the ambitious booster plan laid out by top federal health officials last month as the calendar nears September 20,when officials initially said boosters could be available for......
Read more

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More